Onderneming Dr. Lal PathLabs Limited Bombay S.E.
Aandelen
LALPATHLAB
INE600L01024
Gezondheidszorgvoorzieningen & -diensten
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2.263 INR | -0,28% | +8,81% | -12,11% |
18/03 | Dr Lal Pathlabs benoemt CEO | MT |
17/03 | Dr. Lal PathLabs Limited benoemt Shankha Banerjee tot Chief Executive Officer, met ingang van 21 mei 2024 | CI |
Vakgebied
Aantal werknemers: 4 048
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Laboratories for Carrying Out Pathological Investigations
100,0
%
| 20 873 | 100,0 % | 20 166 | 100,0 % | -3,38% |
Other
0,0
%
| 1 | 0,0 % | 2 | 0,0 % | +85,27% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
India
98,9
%
| 20 734 | 99,3 % | 19 949 | 98,9 % | -3,79% |
International
1,1
%
| 140 | 0,7 % | 220 | 1,1 % | +57,66% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-10-16 | |
Ved Prakash Goel
DFI | Director of Finance/CFO | - | 01-01-06 |
Arvind Lal
CHM | Chairman | 74 | 14-02-95 |
Munender Soperna
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-07 |
Vinay Gujral
CMP | Compliance Officer | - | 01-12-19 |
Vandana Lal
CTO | Chief Tech/Sci/R&D Officer | 66 | 14-02-95 |
Manoj Garg
HRO | Human Resources Officer | - | - |
Corporate Officer/Principal | 58 | 01-02-05 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 58 | 27-07-23 | |
Director/Board Member | 77 | 21-08-15 | |
Arvind Lal
CHM | Chairman | 74 | 14-02-95 |
Vandana Lal
CTO | Chief Tech/Sci/R&D Officer | 66 | 14-02-95 |
Corporate Officer/Principal | 58 | 01-02-05 | |
Rajit Mehta
BRD | Director/Board Member | - | 27-07-23 |
Rahul Sharma
BRD | Director/Board Member | 63 | 22-07-05 |
Director/Board Member | 42 | 17-05-19 | |
Somya Satsangi
BRD | Director/Board Member | 54 | 08-02-19 |
Rohit Bhasin
BRD | Director/Board Member | 64 | 08-11-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 83 477 852 | 36 054 836 ( 43,19 %) | 344 253 ( 0,4124 %) | 43,19 % |
Bedrijfsgegevens
Dr. Lal PathLabs Ltd.
12th Floor, Tower B, SAS Tower Medicity, Sector-38
122001, Gurgaon
+91 12 4301 6500
http://www.lalpathlabs.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,32% | 9,21 mld. | |
-9,54% | 3,67 mld. | |
+39,95% | 3,59 mld. | |
-4,12% | 2,6 mld. | |
-2,84% | 2,01 mld. | |
-16,85% | 1,63 mld. | |
-25,37% | 1,54 mld. | |
-7,98% | 1,12 mld. | |
+2,71% | 1,06 mld. |
- Beurs
- Aandelen
- Aandeel Dr. Lal PathLabs Limited
- Aandeel Dr. Lal PathLabs Limited - Bombay S.E.
- Onderneming Dr. Lal PathLabs Limited